Trials / Completed
CompletedNCT04334213
A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150
A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interactions and Safety After Oral Administration of D745, D150 and CKD-501 in Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Clinical trial to investigate the pharmacokinetic drug interaction and safety of CKD-501, D745 and D150
Detailed description
A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interactions and Safety after Oral Administration of D745, D150 and CKD-501 in Healthy Adults
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-501 | QD, PO |
| DRUG | D745, D150 | QD, PO |
| DRUG | CKD-501, D745, D150 | QD, PO |
Timeline
- Start date
- 2020-05-07
- Primary completion
- 2020-08-05
- Completion
- 2020-08-05
- First posted
- 2020-04-06
- Last updated
- 2020-10-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04334213. Inclusion in this directory is not an endorsement.